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In# brain# biopsies# taken# from# patients# with# rapidly# progressive# dementia,# the# first# differential# diagnoses# to# be# ruled# out# are# prion# diseases.# For# safe# diagnostic# processing# of# tissue# and# instruments,#a#fast,#highly#sensitive#and#specific#analysis#for#prion#aggregates#is#necessary.# # In#our#study#we#examined#16#brain#biopsies#and#brain#samples#(frontal#cortex#and#cerebellum)# from#65#autopsies#by#Western#blot,#paraffinCembedded#tissue#(PET)#blot,#immunohistochemistry# and# the# recently# described# membrane# adsorption# assay# (MAA)# for# their# suitability# to# detect# pathological#prion#protein.## # The#PET#blot#method#provides#in#our#hands#the#highest#sensitivity#in#prion#detection#(biopsies:# 100%;# all# autopsy# sections:# 96.3%),# closely# followed# by# the# MAA# (biopsies:# 100%;# all# autopsy# samples:# 96%)# and# Western# blot# analysis# (biopsies:# 100%;# all# autopsy# samples:# 92%).# Conventional# immunohistochemistry# is# the# least# sensitive# method# (biopsies:# 50%;# all# autopsy# sections:#80%)#and#also#the#one#with#a#false#positive#biopsy#result.## # Consequently,# our# diagnostic# standard# is# to# use# the# MAA# as# a# first# step# to# detect# or# exclude# a# prion# disease,# followed# by# the# PET# blot# for# the# prion# deposition# pattern,# Western# blotting# for# prion# typing# and# immunohistochemistry# for# differential# diagnoses.# With# this# standard# and# the# availability#of#unfixed#tissue,#a#diagnosis#was#possible#in#all#16#biopsies#examined.##

Introduction)
! In# prion# diseases,# also# known# as# transmissible# spongiform# encephalopathies# (TSEs),# a# "proteinacious# infectious# particle"# designated# with# the# acronym# "prion"# resembles# the# infectious# agent# or# a# major# part#of#it#(1).#It#is#the#pathological#isoform#of# the# physiologically# expressed# cellular# prion# protein# (2).# TSEs# are# fatal# diseases# and# decontamination# procedures# for# bacteria,# fungi# and# viruses# do# not# inactivate# pathological# prion# protein# (3),# which# forms# aggregates# and# accumulates# in# the# CNS# during#the#disease#course.## A#brain#biopsy#is#indicated#when#the#clinical# syndrome# is# unclear# and# treatable# diseases# are# among# the# possible# diagnoses.# In# a# patient# with# rapidly# progressive# dementia,# the# exclusion# of# prion# diseases# is# the# first# step# in# the# neuropathological# assessment# once#a#brain#biopsy#has#been#carried#out#(4).# The# most# common# human# prion# disease# is# sporadic# CJD,# with# an# incidence# of# 1C2:# 1.000.000# in# the# human# population# (5).# A# fast,#highly#sensitive#and#specific#analysis#to# determine# whether# or# not# pathological# prion# protein# is# present# in# human# brain# tissue# is# indispensable# for# the# further# processing# of# tissues# for# diagnostic# purposes.# If# considered# prionCpositive,# tissue# samples# can# be# decontaminated# with# formic#acid#to#protect#anyone#handling#them# (6).# The# disadvantage# of# this# procedure# is# the# loss# of# some# epitopes# that# might# be# essential# to# confirm# or# rule# out# differential# diagnoses.# In# addition,# a# prionCpositive# result#will#also#determine#whether#and#how# surgical# instruments# should# be# reprocessed# (7).# Although#criteria#for#the#clinical#diagnosis#of# CJD#are#of#valuable#assistance#(8,#9),#in#cases# of# rapid# progressive# dementia# concerning# patients# of# an# uncommonly# young# age# for# CJD,# other# diagnoses# are# usually# suspected# first.# If# a# prion# disease# is# suspected# and# there# are# any# atypical# features,# a# brain# biopsy# will# be# necessary# to# exclude# a# potentially# treatable# disorder# (10).# Rare# forms#of#sporadic#CreutzfeldtCJakob#disease,# such#as#atypical#CJD#at#a#young#age#(11),#or# sporadic# fatal# insomnia# (sFI)# (12)# can# only# be#definitively#diagnosed#in#the#brain#tissue# itself,#and#unlike#with#genetic#prion#diseases# i.e.#fatal#familial#insomnia#(FFI),#GerstmannC SträusslerCScheinker# syndrome# (GSS)# and# familial# CJD# there# is# no# genetic# disposition# to#aid#the#diagnosis#in!vivo.# In# the# present# study,# we# demonstrate# the# utility# of# the# recently# developed# microC filtration# assay# (13)# for# the# highly# sensitive# detection# of# diseaseCassociated# prion# protein# aggregates# in# sporadic# CJD,# FFI# and# GSS.# This# technique# differs# from# conventional#dot#blotting#(14)#by#processing# higher#amounts#of#equivalent#tissue#thereby# providing# a# higher# sensitivity.# The# concept# of# microfiltration# is# not# new# in# itself,# but# it# has#never#been#used#as#an#approved#tool#in# the# diagnostics# of# human# prion# diseases.# Established# working# protocols# for# nonC humans# demonstrate# the# utility# of# the# method# (15),# but# they# are# more# laborious# and#less#sensitive#than#the#MAA.# Our# study# aims# to# find# the# most# secure# procedure# to# diagnose# or# exclude# prion# diseases#in#brain#biopsies.#As#brain#biopsies# of#some#prion#diseases,#e.g.#FFI#patients,#are# hard# to# come# by,# we# used# brain# samples# from# autopsies# in# addition# to# biopsies# to# validate# four# methods.# We# compare# the# MAA# to# the# paraffinCembedded# tissue# blot# (PET# blot),# Western# blot# and# conventional# immunohistochemistry# with# regard# to# sensitivity#and#specificity.## #
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Material)and)Methods) )
Material!
We# examined# brain# tissue# from# 16# biopsies# and#65#autopsies#coming#from#patients#with# suspected# CJD# who# were# routinely# examined# by# the# German# National# CJD# Surveillance.# The# investigation# was# approved# by# the# Ethics# Committee# of# the# 
Western! blot! and! membrane! adsorption!assay!(MAA)! Autopsies!
We# examined# frontal# cortex# samples# of# 63# autopsy# cases# and# also,# if# available,# cerebellar#tissue#(n=59).## With# the# MAA,# pathological# prion# protein# was# detected# in# all# available# frontal# cortex# autopsy# samples# in# which# a# prion# disease# had# been# diagnosed,# therefore# providing# a# sensitivity# of# 100%# (table# 3b).# However,# in# one# FFI# case# a# retake# with# different# homogenates# from# the# frontal# cortex# showed# an# inconsistent# detection# (table# 2,# FFI05;# Figure# 1a,# lane# 9).# Parietal# cortex# of# the# GSS# patient# (SD03,# table# 2)# exhibited# abundant# amounts# of# prion# aggregates# (Figure# 1a,# lane# 7).# In# cerebellum# samples# the# presence# of# pathological# prion# protein# was# shown# by# MAA# in# all# sporadic# CJD# patients# except# one# (CJD18,# table# 2).# The# two# available# FFI# cerebellum# samples# appeared#to#be#prionCfree#with#this#method.# Therefore,# the# sensitivity# for# all# examined# autopsy# samples# was# 96%# with# the# MAA# (table# 3c).# No# crossCreaction# with# protein# aggregates# of# other# neurodegenerative# diseases#was#observed#(Figure#1a).#Dilution# steps# allowed# a# rough# prion# quantification# which#helped#to#adjust#sample#quantities#of# brain#wet#weight#for#SDSCPAGE#and#Western# blot#in#order#to#achieve#a#valid#typing#of#the# prion# disease# according# to! Parchi# and# colleagues#(19).# Western! blot! analysis! confirmed# most# positive#results#of#the#MAA#by#displaying#the# typical# threeCbanded# pattern# of# the# partly# proteinase# KCresistant# pathological# prion# protein#with#a#size#between#19#and#37#kDa.# Prion# was# detected# with# a# sensitivity# of# 94.9%# in# the# frontal# biopsy# site# (table# 3b)# and# 92%# in# all# examined# neuroanatomical# autopsy# sites.# In# addition# to# all# samples# tested# negative# for# prion# protein# with# the# MAA# (i.e.# the# nonCprion# cases# plus# three# cerebellum# samples),# three# further# samples# appeared# to# be# prionCnegative# by# Western# blot# analysis:# cerebellum# of# another# case# of# sporadic# CJD# (CJD13,# table# 2)# and# frontal# cortex# from# two# of# the# six# examined# FFI# cases# (FFI03# und# FFI05,# table# 2).# Repeated# Western# blots# of# these# three# cases# with# different# homogenates# and# sample# quantities# up# to# 250# µg# brain# wet# weight# were# unsuccessful.# The# other# FFI# cases# revealed# the# characteristic# FFICprion# pattern# in# the# frontal# cortex# with# pronounced# monoC# and# diglycosylated# fragments# and# an# unglycosylated# fragment# of# 19# kDa# (e.g.# Figure# 1b,# lanes# 8# and# 10).# The#parietal#cortex#of#the#GSS#case#exhibited# a# smallCsized# fragment# of# approximately# 8C 10# kDa# in# addition# to# the# threeCbanded# prion#pattern!(Figure#1b,#lane#7).#Of#the#33## 
!Increasing!the!accuracy!to!diagnose!prion!diseases!! !
AD01 MM AD - - - - - - - - AD02 MM AD - - - - - - - - AD03 VV AD - - - - - - - - AD04 MV AD - - - - - - - - AD05 MV AD - - - - - - - - AD06 MM genetic AD - - - - - - - - AD07 MM genetic AD - - - - - - -DLB01 MM DLB - - - - - - - - DLB02 MV DLB - - - - - - - - DLB03 MV DLB - - - - - - - - DLB04 MV DLB - - - - - - - - DLB05 MM DLB - - - - - - - - PD01 MM PD - - - - - - - - PD02 MV PD - - - - - - - - PD03 MV PD - - - - - - - - CAA01 VV CAA - - - - - - - - CAA02 MV CAA - - - - - - - - MID01 MM MID - - - - - - + b - MID02 MM MID - - - - - - - - SD01 MV limbic encephalitis - - - - - - - - SD02 MM FTD - - - - - - - -
